Press Releases about Silence Therapeutics Plc ADR
![](https://mms.businesswire.com/media/20240627515407/en/2171687/5/Silence-Logo-FINAL-rgb.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240620544030/en/2164679/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240530788603/en/2144466/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240516057102/en/2132956/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240430303611/en/2111334/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240429453581/en/2111976/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240408451903/en/2091996/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240313711941/en/2064742/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240313160113/en/2064736/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240228761492/en/2047118/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240223959968/en/2043035/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20240205069427/en/2021560/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20240131830456/en/2012525/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20231201341026/en/1956670/22/Marie_Lindholm.jpg)
![](https://mms.businesswire.com/media/20231114340624/en/1943892/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20231108841473/en/1936077/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231101637440/en/1931184/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230926933986/en/1897497/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230906810931/en/1881476/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics to Participate in September Investor Conferences
September 06, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230816529739/en/1868267/5/Silence-Logo-FINAL-rgb.jpg)
Silence Therapeutics Reports Second Quarter 2023 Results
August 16, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230711209680/en/1834453/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230531005007/en/1800166/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230516005922/en/1795554/5/Silence-Logo-FINAL-rgb.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230504005217/en/1783063/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230501005060/en/1777824/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230425005251/en/1772658/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230404005161/en/1754366/5/Silence-Logo-FINAL-rgb.jpg)
![](https://mms.businesswire.com/media/20230329005111/en/1749363/5/Silence-Logo-FINAL-rgb.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.